Most patients (82.6%) had minimal psoriasis skin involvement with a body surface area of < 3. However, 15.1% and 2.4% had a body surface area involvement of 3 – 10% and > 10, respectively.
Patients with autoimmune inflammatory rheumatic diseases should be screened for tuberculosis, hepatitis B and other infections before starting disease-modifying antirheumatic drugs, according to new guidelines published by EULAR.